19 Apr 2019 --- A study of cannabidiol (CBD) has found that the non-psychoactive compound in cannabis could have a new application as a “Trojan horse” – helping slip medications across the blood-brain barrier (BBB) and into the brain. Research of this effect was conducted by scientists at the Complutense University in Spain, through a mouse study. Medication absorbed quicker and more efficiently with help from CBD reduces the need for high dosages, thus lowering the risk of toxicity, according to the researchers. The report was published in the ACS journal Molecular Pharmaceutics.